Group One Trading’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Group One Trading’s Portfolio TCRR Stock Details TCRR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-800	Closed	-$1.2K	–	8456
2023 Q1	$1.2K	Buy	+800	New	+$1.08K	﹤0.01%	6748
2022 Q3	–	Sell	-587	Closed	-$1.7K	–	8522
2022 Q2	$2K	Buy	587 +508	+643%	+$1.25K	﹤0.01%	7479
2022 Q1	$0	Buy	+79	New	+$248	﹤0.01%	9006

Group One Trading's TCRR Position: Q2 2023 in Review

Group One Trading sold out of TCR2 Therapeutics Inc. Common Stock (TCRR) in Q2 2023, closing a stake of 800 shares — an estimated $1.2K sold.

Group One Trading first reported a position in TCRR in Q1 2022 and held it in 3 quarters. The position peaked at $2K in Q2 2022. 0 funds tracked by Wall St. Rank hold TCRR as of Q2 2023.

Group One Trading reported no remaining TCR2 Therapeutics Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Group One Trading sold 800 TCR2 Therapeutics Inc. Common Stock shares in Q2 2023, an estimated $1.2K.
Group One Trading first reported a position in TCR2 Therapeutics Inc. Common Stock in Q1 2022 and held it in 3 quarters.
Group One Trading's TCR2 Therapeutics Inc. Common Stock position peaked at $2K in Q2 2022.
0 funds tracked by Wall St. Rank held TCR2 Therapeutics Inc. Common Stock as of Q2 2023.

Based on Group One Trading's 13F filing for Q2 2023, filed 9 Aug 2023.